INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Parkinson’s disease typically develops between the ages of 55 and 65 years and occurs in 1 to 2% of persons over the age of 60 years. Approximately 0.3% of the general population is affected, and the prevalence is higher among men than women, with a ratio of 1.6 to 1.0. As the population ages, the incidence of PD is expected to increase dramatically in the coming decades. Current therapies are largely based on dopamine replacement strategies using the dopamine precursor levodopa. However, chronic treatment is accompanied by the development of motor complications and the disease progresses inexorably. Moreover, disease progression is associated with the emergence of symptoms such as freezing, falls, and dementia that cannot be adequately controlled with dopaminergic therapy. Indeed, these non-dopaminergic traits are now recognized to be common and a major cause of disability in patients with progressive disease. Many different treatments and therapeutic strategies have been evaluated, and many promising approaches are currently being tested in the laboratory and clinic. As a result, many new therapeutics and strategic approaches to treat different stages of Parkinson's disease have become available. Treatment for Parkinson's disease typically involves a combination of treatments. An important part of Parkinson's disease treatment is drug therapy supported by various combination therapies. Treatment is primarily aimed at relieving symptoms and side effects, as the disease itself cannot currently be cured. Each Parkinson's disease course is different, and the type and severity of symptoms vary widely. What is particularly worrying to one person may not be noticed by another. In addition to symptoms, medical history, age, and living environment also play an important role. Therefore, individualized treatment is necessary.
Keywords:
Parkinson's disease, neurodegenerative disorders, dopamine, levodopa, dopaminergic therapy, dementia, non-dopaminergic traits, medical history, combination therapies, etc.
Cite Article:
"ALTERNATIVE TREATMENT OF PARKINSONS DISEASE: A REVIEW", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.c18-c37, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211204.pdf
Downloads:
000118745
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn